During the past decade, ASCARDIO conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "ASCARDIO" #1 collaborator was "Consejo Interamericano de Falla Cardíaca e Hipertensión Pulmonar (CIFACAH)" with 1 trials as a collaborator and "Sociedad Interamericana de Cardiología (SIAC)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "ASCARDIO" are "Bradycardia" (1 trials), "Device Malfunction" (1 trials), "Device Related Infection" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "ASCARDIO" in a lesser frequency.

Most popular intervention types in "ASCARDIO" are "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "New Pacemaker" (1 trials) and "Reconditioned Pacemaker" (1 trials). Other intervention names were less common.

The vast majority of trials in "ASCARDIO" are 2 trials for "All" genders.

Currently, there are NaN active trials in "ASCARDIO". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in ASCARDIO, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ASCARDIO, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".